Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Amplyx Pharmaceuticals
3210 Merryfield Row
San Diego, CA 92121
Phone: 858-348-4458
http://amplyx.com/

Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The company's lead compound, APX001, will enter clinical development in 2016 and has shown broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus, as well as high potency against rare, difficult-to-treat molds. Amplyx has raised $42.5 million in venture capital and received more than $10 million in grants from the National Institutes of Health to supports its drug discovery and development efforts. The company's research operations are located at Johnson & Johnson Innovation, JLABS in San Diego, Calif.

Key Contact
Name
Mike Grey
Title
CEO
Funding Events

Date
Amount
Type
Investors
11/11/15 $40,500,000 Series B BioMed Ventures
RiverVest Venture Partners
02/09/16 $8,700,000 Series B 3x5 Partners
08/02/17 $67,000,000 Series C 3x5 Partners
Arix Bioscience
BioMed Ventures
Lundbeckfond Ventures
Pappas Ventures
RiverVest Venture Partners
Sofinnova Ventures
05/19/20 $53,000,000 Series C Extension 3x5 Partners
Adage Capital Management
Arix Bioscience
BioMed Ventures
Lundbeckfonden Ventures
New Enterprise Associates
Pappas Capital
Pfizer Venture Investments
RiverVest Venture Partners
Sofinnova Ventures